All Chemistry World articles in May 2018
View all stories from this issue.
-
Review
The many lives of carbon
Dag Olav Hessen leaves no stone - or diamond - unturned in his account of element six
-
Review
Built: the hidden stories behind our structures
The ‘storey’ of structural engineering, as told by Shard designer Roma Agrawal
-
Puzzle
On the spot: Expert reviewer
Should you review a paper that covers research you also work on?
-
Review
Seeds of science: why we got it so wrong on GMOs
Katrina Kramer reviews the story of one man’s journey from activist to advocate
-
Feature
The molecular basis of circadian rhythms
Every cell of every organism has its own little clock, but what makes it tick? Fiona Case finds out
-
Opinion
Douma and Salisbury: a tale of two cities
Events in Salisbury and Douma show how important OPCW has become
-
Opinion
The clues that let you trace a single sheet of paper
Forensic science has a new way to detect document fraud
-
Business
Big business computing
Chemical and oil firms are using supercomputers to improve every part of their operations. Angeli Mehta reports
-
-
-
-
Opinion
What the pay gap report really means
The UK pay gap data is an important first step, not the last word
-
Opinion
A sideways look at synthesis
Side products might not be what you want, but they could be what you need
-
Opinion
Jean-Pierre Sauvage: 'You'd be surprised about my taste in music!'
The molecular machine maven talks reading, Jagger and winning a Nobel prize
-
Opinion
Suffering students: mental health in academia
We can all play a part in promoting good student mental health
-
Review
Science not silence: voices from the March for Science movement
22 April 2017 remembered through a collection of photos and stories
-
Feature
3D printing in pharma
Nina Notman explores how 3D printing is carving out a niche for itself in the pharmaceutical industry
-
-
Opinion
Why you should care about Fair data
The benefits of findable, accessible, interoperable and re-useable information
-
Opinion
Why combination pills aren’t always the answer
The challenges of medicines containing multiple drugs aren’t going away